Cibus Reports 63% Revenue Decline in Q3 2025, Reduces Operating Losses

Cibus, Inc. reported a significant decline in financial performance for the third quarter of 2025, with revenues of $615,000, down 63% from $1.67 million in the same period last year. For the nine months ending September 30, 2025, total revenue was $2.58 million, a decrease of 15% compared to $3.05 million in the prior year. The company attributed this decline primarily to reduced earnings from collaboration agreements related to contract research for Rice and Sustainable Ingredients. Despite the drop in revenue, Cibus managed to reduce its operating expenses, with research and development costs decreasing by 17% to $10.78 million and selling, general, and administrative expenses down 31% to $5.27 million.

Cibus experienced a notable improvement in its loss from operations, which was $15.44 million for the third quarter of 2025, a substantial reduction from a loss of $200.44 million in the same quarter of 2024. The company did not incur any goodwill impairment in the latest quarter, contrasting sharply with the previous year's impairment of $181.43 million. This shift contributed to a net loss of $24.30 million for the third quarter, significantly lower than the $201.46 million loss reported in the prior year. For the nine-month period, the net loss was $100.25 million, down from $256.91 million in 2024.

Strategically, Cibus has been focusing on streamlining its operations and reducing costs. In July 2025, the company announced a workforce reduction of approximately 34 employees as part of its restructuring initiative aimed at preserving capital resources. The company expects these measures to lower its annual cash burn to around $30 million by 2026. Additionally, Cibus is concentrating its efforts on the commercial advancement of its weed management traits for Rice, which it believes could yield over $200 million in annual royalties upon full commercialization.

Operationally, Cibus has made strides in its product development, particularly in its Rice and Canola platforms. The company has engaged in material transfer agreements with seed companies in Latin America to advance the commercialization of its herbicide tolerance traits. As of September 30, 2025, Cibus had $23.89 million in cash and cash equivalents, with current liabilities totaling $20.6 million. The company anticipates that it will continue to incur losses in the coming years, necessitating additional capital to support its operations and business plans.

Looking ahead, Cibus is focused on securing further funding through various avenues, including commercialization activities and potential public or private equity financing. The company acknowledges that its current cash reserves may not be sufficient to sustain operations for the next 12 months without additional capital. Cibus is actively pursuing strategies to enhance its financial stability while navigating the challenges posed by market conditions and ongoing operational adjustments.